Linked page lives on the broker site, not on OpenAcquisitions.
Key points
•Contract research organization providing mass spectrometry services to biotech and pharma clients.
•Proprietary bioinformatics automation reduces proteomics analysis time from two weeks to two hours.
•Revenue grew from $1.1M in 2023 to $2M in 2025.
•Business demonstrates significant operational efficiency gains and client value proposition through automation technology.
Business description
Mass spectrometry CRO serving biotech and pharma grew revenue from $1.1M in 2023 to $2.1M in 2025 through organic growth alone, with instruments running at only 50-70% utilization and zero dedicated sales staff.
